SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-102661
Filing Date
2022-09-23
Accepted
2022-09-23 16:01:46
Documents
14
Period of Report
2022-09-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2226513d1_8k.htm   iXBRL 8-K 33222
2 EXHIBIT 10.1 tm2226513d1_ex10-1.htm EX-10.1 172524
3 EXHIBIT 10.2 tm2226513d1_ex10-2.htm EX-10.2 17823
  Complete submission text file 0001104659-22-102661.txt   444906

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA axla-20220920.xsd EX-101.SCH 3048
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE axla-20220920_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axla-20220920_pre.xml EX-101.PRE 22605
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2226513d1_8k_htm.xml XML 3593
Mailing Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139 617-868-0949
Axcella Health Inc. (Filer) CIK: 0001633070 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38901 | Film No.: 221262303
SIC: 2836 Biological Products, (No Diagnostic Substances)